ArtiQ obtains CE marking for automated interpretation of pulmonary function tests

ArtiQ obtains CE marking for automated interpretation of pulmonary function tests

Startup ArtiQ announces that it has obtained CE marking for ArtiQ.PFT, a software using artificial intelligence (AI) for automated interpretation of pulmonary function tests (PFTs) to support diagnosis of lung diseases. The software automates report writing, allowing doctors to spend more time with their patients and ensuring all reports are according to the latest international standards. Additionally, the software predicts the probability of lung diseases almost twice as accurately as a pulmonologist. This holds the potential to come to a final diagnosis with fewer additional tests. 

The CE marking allows ArtiQ to bring ArtiQ.PFT to hospitals in Europe. This is in line with the company's plan to deploy the technology in multiple Belgian centers in the coming months and expand internationally quickly after.

"Obtaining the CE mark is an essential milestone in following our strategy to bring ArtiQ.PFT to the market and support doctors in the diagnosis, treatment and monitoring of respiratory diseases," says Marko Topalovic, CEO and co-founder of ArtiQ, “In the next year, we will not only build the European market, but also start preparing to expand to other markets such as the US.”

Almost 40.000 patients at UZ Leuven, more to come in other hospitals

Currently, the pulmonologist interprets the test results and writes the reports according to the international guidelines. By providing an accurate description and interpretation in real time, the ArtiQ software is supporting physicians who can focus on the next steps in patient care such as patient consultation, deciding on additional tests needed, and proposing a treatment strategy. 

Prof. Wim Janssens, pulmonologist and co-founder of ArtiQ, comments: "Pulmonary function tests provide extensive numerical outputs, and their patterns need to be interpreted within a clinical context to come to a diagnosis. We found that computers are about twice as accurate as pulmonologists. At UZ Leuven we already used the technology on close to 40.000 patients, the CE mark will now allow other hospitals to access this powerful software as well." 

With its cloud-based technology, ArtiQ.PFT can be coupled and synchronized with electronic patient records or directly linked to PFT machines. Upon testing their patients, pulmonologists and other clinicians can receive an automatically generated report in their patient files.

Learn more at the annual Congress of the European Respiratory Society in Madrid, 28th of September - 2nd of October.

About ArtiQ

ArtiQ is a spin-off company from the KU Leuven dedicated to supporting doctors in the diagnosis, treatment and monitoring of respiratory diseases. The company was founded early 2019 by four committed founders with an extensive history in respiratory medicine, medical devices, and artificial intelligence. The startup is part of Start it @KBC, the largest accelerator for startups in Belgium. ArtiQ closed its seed financing round in June 2019. The investors are KBC Focus Fund, the KU Leuven Gemma Frisius Fund, University Hospitals Leuven and private investor Bart Swaelens.

Contact us
About Start it @KBC

Start it @KBC supports and promotes entrepreneurs with innovative ideas and scalable business models. As such, it is Belgium’s largest community of start-ups. As a pioneer in Belgium, Start it @KBC aims to have a positive impact on the country’s economy and society. 

For their first 3 months at Start it @KBC, start-ups join a strong, tailor-made accelerator programme while continuing to profit from top-notch mentorship, diverse expertise, an extensive international network and an inspiring co-working space for a period of 12 months. Start it @KBC continuously adapts its programme in co-creation with its start-ups.  

One of Start it @KBC’s key objectives is to stimulate (international) cross-pollination between more than 700 start-ups and scale-ups but also amongst investors, experienced mentors, experts from a wide variety of domains (technology, sales, legal, marketing, communication, etc.) and other global accelerators and incubators. The community also plays a leading role in promoting diversity and female entrepreneurship. 

Start it @KBC also has a clear international vision. In addition to hubs in Antwerp, Brussels, Ghent, Hasselt, Leuven, Kortrijk and Budapest, the community also includes a presence in New York. As of 2017, Start it @KBC has been a member of the Global Accelerator Network (GAN), a select network of 120 global accelerator programmes, offering extra opportunities for start-ups on the international stage and up to 1 million dollars’ worth of exclusive advantages from technology partners.

Via the Start it @KBC’s Corporate Incubation Program, start-up teams within large companies have also been able to transform innovative ideas into fully-fledged businesses under the guidance of Start it @KBC. 

Start it @KBC was established in 2014. Today it is a partnership between AccentureCronos GroepFlanders DCimecjoynKBCMobile VikingsPfizerTelenet Kickstart, University of Antwerp and local academic partners. 

Start-ups can apply throughout the year via the website (www.startit.be). The selected founders pitch for a professional jury twice a year, and a new group of start-ups start their entrepreneurial trajectory.

For more information: www.startit.be
For Start it @KBC logos and images: startitkbc.prezly.com/media
Press kit Start it @KBC

Start it @KBC
Sint-Pietersvliet 7
2000 Antwerpen